Sep / 2025

OncoDaily IO OncoDaily GI Hemostasis Today

06/03/2024

Mar 6, 2024 11:34 am

Mar 6, 2024 11:30 am

Mar 6, 2024 11:17 am

Mar 6, 2024 11:12 am

Mar 6, 2024 10:51 am

Mar 6, 2024 10:44 am

Mar 6, 2024 9:52 am

Mar 6, 2024 9:47 am

Mar 6, 2024 9:42 am

Mar 6, 2024 9:25 am

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

06/03/2024

Rami Manochakian: U.S. FDA approves Amivantamab WITH CHEMOTHERAPY for 1st Line treatment of advanced non-small cell Lung Cancer with EGFR

Maite Gorostegui: It doesn’t matter where you live, watch our videos about the importance of local research

Celebrating Women’s History Month – American Cancer Society

Dinesh Pendharkar: District cancer care model appears to be most promising over ten years

Guru Sonpavde: Phase I clinical trial early drug development update from AdventHealth Central Florida

Erman Akkus: H. Pylori and Colorectal Cancer

Tracey O’Brien: Australia’s deadliest and arguably most stigmatised cancer, is on the verge of a potentially monumental shift

Ravi Singh: The breadth and quality of the research presented by our graduate students at Wake Forest University never ceases to impress me

Wafik El-Deiry: The founders of the WIN Consortium had a bold vision for global impact in personalized cancer medicine

Sendurai Mani: I am privileged to present at this distinguished gathering organized by the WIN Consortium in cancer personalized medicine and Burjeel Holdings

Headlines

06/03/2024

Rami Manochakian: U.S. FDA approves Amivantamab WITH CHEMOTHERAPY for 1st Line treatment of advanced non-small cell Lung Cancer with EGFR

Maite Gorostegui: It doesn’t matter where you live, watch our videos about the importance of local research

Celebrating Women’s History Month – American Cancer Society

Dinesh Pendharkar: District cancer care model appears to be most promising over ten years

Guru Sonpavde: Phase I clinical trial early drug development update from AdventHealth Central Florida

Erman Akkus: H. Pylori and Colorectal Cancer

Tracey O’Brien: Australia’s deadliest and arguably most stigmatised cancer, is on the verge of a potentially monumental shift

Ravi Singh: The breadth and quality of the research presented by our graduate students at Wake Forest University never ceases to impress me

Wafik El-Deiry: The founders of the WIN Consortium had a bold vision for global impact in personalized cancer medicine

Sendurai Mani: I am privileged to present at this distinguished gathering organized by the WIN Consortium in cancer personalized medicine and Burjeel Holdings

Headlines

OncoDaily

Oncology

cancer

fight against cancer

Global fight against cancer

cancer care

Breast Cancer

ASCO

Lung cancer

Cancer research

MD Anderson Cancer Center

cancer awareness

NSCLC

ESMO

immunotherapy

cancer treatment

Research

ASCO24

Headlines

colorectal cancer

Childhood Cancer

prostate cancer

AACR

clinical trials

FDA

Dana-Farber Cancer Institute

UICC

American Cancer Society

European Cancer Organisation

NCI

National Cancer Institute

healthcare

SIOP

ASCO25

chemotherapy

Vivek Subbiah

AI

American Society of Clinical Oncology

Paolo Tarantino

IASLC

WHO

Robert Orlowski

multiple myeloma

Memorial Sloan Kettering Cancer Center

Zainab Shinkafi-Bagudu

radiation oncology

Myeloma Paper of the Day

cervical cancer

Myeloma

patient care

European School of Oncology

Sitemap